Zhengye Biotechnology Holding Ltd: which funds bought and sold
Institutions that bought and sold Zhengye Biotechnology Holding shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 2 institutions that filed 13F reports for both quarters added to or opened positions in Zhengye Biotechnology Holding, and 4 cut or closed them. Together they sold a net 21K shares, −17.2% on what they held at the start of the quarter. Active managers and hedge funds on our list were net sellers of 21K shares (−61.9%); index fund managers held the same number of shares overall. 1 opened a new position and 1 sold out entirely.
Bought, Q2 2026 2 institutions, 1 of them new holders Sold, Q2 2026 4 institutions, 1 of them sold out
Net change, all compared −21K shares (−17.2%)
Net change, active managers −21K shares (−61.9%), 0 bought, 1 sold
Buyers versus sellers
2 bought 3 4 sold
Active managers and hedge funds 0 bought · 1 sold · −21K
Index fund managers 0 bought · 0 sold · 0
Other institutions 2 bought · 3 sold · −116
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Xtx Topco Ltd | +4,719 +10.7% | 49K | $33,086 |
| Jpmorgan Chase & Co | +134 New position | 134 | $93 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| None of the active managers on our list. | |||
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Winton Group Ltd Hedge fund | −21K −61.9% | 13K | $8,619 |
| Tower Research Capital LLC (TRC) | −4,912 Sold out | 0 | — |
| UBS Group AG | −44 −0.5% | 7,992 | $5,410 |
| Morgan Stanley | −13 −5.0% | 248 | $168 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Winton Group Ltd Hedge fund | −21K −61.9% | 13K | $8,619 |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Jpmorgan Chase & Co | 134 | $93 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 4,912 | $4,592 |
Who holds the shares
- Institutions reporting
- 8
- Ten largest holders
- 100.0% of 13F-reported shares
- Index fund managers
- 29.0% of 13F-reported shares
- Active managers and hedge funds
- 12.7% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 0 | 1 | 0 | 0 | −21K | −61.9% |
| Index fund managers | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Other institutions | 2 | 3 | 1 | 1 | −116 | −0.2% |
← Back to Zhengye Biotechnology Holding Ltd · Insiders · Politicians